Market Cap 639.90B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 24.56
Forward PE 22.84
Profit Margin 28.46%
Debt to Equity Ratio 0.44
Volume 8,219,500
Avg Vol 8,396,254
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 35%
Beta 0.24
Analysts Strong Sell
Price Target $273.25

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
TraderDaKing
TraderDaKing Jul. 31 at 2:41 PM
$ELTP $GME $JNJ $META Spread the Word. ELTP is the Bird.... Its Flying to Dollar-land. Up-listing and SequestOx deal going to happen. This lady was going to get SequestOx launched, Big Pharma does not want this to happen. Look it up. Now RFKjr and others are getting it done. Its still a Fight, so get involved Call you Congress person. https://elitepharma.com/ SequestOxTM (ELI-200) Opioid Pain NDA Submitted Pending Approval This will Save Lives. Its personal for me not just business.
0 · Reply
bitra
bitra Jul. 31 at 2:39 PM
$JNJ $LEGN what is the BO share price you are expecting?
0 · Reply
clan
clan Jul. 31 at 2:23 PM
$ELTP Elite is an elite cash-generating machine. $SPY $TEVA $JNJ 👀
0 · Reply
Wallstfan
Wallstfan Jul. 31 at 1:42 PM
$JNJ adding more under $254. This will hit new highs soon enough!
0 · Reply
Biotechsamy
Biotechsamy Jul. 31 at 1:28 PM
$LEGN When it comes to $LEGN , J&J only wants the second 50% of Carvykti, no R&D labs in China. Genscript is ready to cash in. Step 1: The Spin. $LEGN packages its Nanjing R&D labs and solid tumor pipeline into a brand new company ("Legend R&D"). They distribute shares of this new entity to current shareholders (GenScript) as a completely tax-free spin-off. Step 2: The BO. Once the R&D is spun out, the original $LEGN corporate shell is left holding exactly one asset: the remaining 50% of the Carvykti rights. J&J then simply acquires this "legacy" shell for all-cash premium. Why it works: It completely bypasses the brutal double corporate taxation of an Asset Purchase Agreement. This is the exact playbook Pfizer used to carve out Biohaven. $JNJ gets the cash cow, GenScript keeps the R&D, and $LEGN shareholders get the ultimate payday. I think we'll see some type of business development transaction in within next 6 months. R&D spin-off to a separate publicly traded company.
0 · Reply
profit_guru
profit_guru Jul. 31 at 1:19 PM
$ABBV - competition to skyrizi from $JNJ is big red flag for the high multiple going forward…near term 230..,imo
0 · Reply
dewmoore
dewmoore Jul. 31 at 12:47 PM
$SLS 81 days since the 78th event was announced (May 11). The old ~22-day baseline is DEAD. We are deeply in uncharted territory now, and the silence means the survival tail is real. The 80th could drop any day, triggering the final countdown to data. The silence from Sellas is deafening because the biology talks: dual MHC Class I & II activation creates a self-sustaining defense system patrolling for YEARS. Off-the-shelf, no toxic chemo, no donor search. Responders aren't just surviving—they’re functionally CURED. Big Pharma ($MRK,$JNJ, $LLY,$PFE) is watching closely. When the curative BOMB drops: $10B Buyout** $46/share $20B Buyout** $92/share $30B Buyout** $138/share $40B Buyout** $184/share ****Gilead's $5B failed AML drug puts $SLS at $23 / share ****Pfizer/Seagen's $40B FAILED cancer drug puts $SLS at $184/ share The gap between short ignorance and biological reality is the opportunity of a lifetime. NDA's are likely signed BUT I’d be putting my bid in NOW. 🚀 Happy Friday!
1 · Reply
cwEWF
cwEWF Jul. 31 at 11:39 AM
$JNJ extend higher as anticipated in (5) that ended at 281 high within rally from daily #bluebox area Now it should either correcting rally from May-2026 low before continue rally or can be correcting big against Jan-2025 low. Chasing long at this stage is risky. #Elliottwave
0 · Reply
HydrogenH2
HydrogenH2 Jul. 31 at 11:06 AM
$DJT $UNH $JNJ $SPY https://www.theguardian.com/commentisfree/2026/jul/30/us-public-rfk-jr-america-healthy-europe-wellness-fads
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Jul. 31 at 4:22 AM
Top Stock Losers Today — July 30, 2026: $JNJ -- −2.54% $DIS -- −2.53% $JMKE -- −9% From IPO Price $MAGNUM.NSE https://truthsandnews.com/markets/10-top-stock-losers-today-july-30-2026-carvana-arm
0 · Reply
Latest News on JNJ
Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:38 PM EDT - 1 day ago

Johnson & Johnson lowers 2026 profit forecast


Explainer: Can J&J finally put the talc litigation behind it?

Jul 29, 2026, 12:01 PM EDT - 1 day ago

Explainer: Can J&J finally put the talc litigation behind it?


Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 12:26 PM EDT - 2 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits


J&J offers $5.5bn to settle baby powder lawsuits

Jul 28, 2026, 12:31 AM EDT - 3 days ago

J&J offers $5.5bn to settle baby powder lawsuits


DePuy Synthes Acquires Expanding Innovations™

Jul 16, 2026, 8:00 AM EDT - 15 days ago

DePuy Synthes Acquires Expanding Innovations™


Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 16 days ago

Johnson & Johnson Earnings Call Transcript: Q2 2026


Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 16 days ago

Johnson & Johnson Slides: Q2 2026


Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 16 days ago

Johnson & Johnson Earnings release: Q2 2026


Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 16 days ago

Johnson & Johnson Quarterly report: Q2 2026


Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:35 AM EDT - 16 days ago

Johnson & Johnson Hikes Guidance, Stock Falls


Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:33 AM EDT - 16 days ago

Johnson & Johnson Bumps Up Guidance as Sales Rise


Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 15, 2026, 6:20 AM EDT - 16 days ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook


The Big 3: UNH, KO, JNJ

Jul 9, 2026, 1:00 PM EDT - 21 days ago

The Big 3: UNH, KO, JNJ

KO UNH


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 7 weeks ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 7 weeks ago

Johnson & Johnson to buy Firefly Bio for $1 billion


TraderDaKing
TraderDaKing Jul. 31 at 2:41 PM
$ELTP $GME $JNJ $META Spread the Word. ELTP is the Bird.... Its Flying to Dollar-land. Up-listing and SequestOx deal going to happen. This lady was going to get SequestOx launched, Big Pharma does not want this to happen. Look it up. Now RFKjr and others are getting it done. Its still a Fight, so get involved Call you Congress person. https://elitepharma.com/ SequestOxTM (ELI-200) Opioid Pain NDA Submitted Pending Approval This will Save Lives. Its personal for me not just business.
0 · Reply
bitra
bitra Jul. 31 at 2:39 PM
$JNJ $LEGN what is the BO share price you are expecting?
0 · Reply
clan
clan Jul. 31 at 2:23 PM
$ELTP Elite is an elite cash-generating machine. $SPY $TEVA $JNJ 👀
0 · Reply
Wallstfan
Wallstfan Jul. 31 at 1:42 PM
$JNJ adding more under $254. This will hit new highs soon enough!
0 · Reply
Biotechsamy
Biotechsamy Jul. 31 at 1:28 PM
$LEGN When it comes to $LEGN , J&J only wants the second 50% of Carvykti, no R&D labs in China. Genscript is ready to cash in. Step 1: The Spin. $LEGN packages its Nanjing R&D labs and solid tumor pipeline into a brand new company ("Legend R&D"). They distribute shares of this new entity to current shareholders (GenScript) as a completely tax-free spin-off. Step 2: The BO. Once the R&D is spun out, the original $LEGN corporate shell is left holding exactly one asset: the remaining 50% of the Carvykti rights. J&J then simply acquires this "legacy" shell for all-cash premium. Why it works: It completely bypasses the brutal double corporate taxation of an Asset Purchase Agreement. This is the exact playbook Pfizer used to carve out Biohaven. $JNJ gets the cash cow, GenScript keeps the R&D, and $LEGN shareholders get the ultimate payday. I think we'll see some type of business development transaction in within next 6 months. R&D spin-off to a separate publicly traded company.
0 · Reply
profit_guru
profit_guru Jul. 31 at 1:19 PM
$ABBV - competition to skyrizi from $JNJ is big red flag for the high multiple going forward…near term 230..,imo
0 · Reply
dewmoore
dewmoore Jul. 31 at 12:47 PM
$SLS 81 days since the 78th event was announced (May 11). The old ~22-day baseline is DEAD. We are deeply in uncharted territory now, and the silence means the survival tail is real. The 80th could drop any day, triggering the final countdown to data. The silence from Sellas is deafening because the biology talks: dual MHC Class I & II activation creates a self-sustaining defense system patrolling for YEARS. Off-the-shelf, no toxic chemo, no donor search. Responders aren't just surviving—they’re functionally CURED. Big Pharma ($MRK,$JNJ, $LLY,$PFE) is watching closely. When the curative BOMB drops: $10B Buyout** $46/share $20B Buyout** $92/share $30B Buyout** $138/share $40B Buyout** $184/share ****Gilead's $5B failed AML drug puts $SLS at $23 / share ****Pfizer/Seagen's $40B FAILED cancer drug puts $SLS at $184/ share The gap between short ignorance and biological reality is the opportunity of a lifetime. NDA's are likely signed BUT I’d be putting my bid in NOW. 🚀 Happy Friday!
1 · Reply
cwEWF
cwEWF Jul. 31 at 11:39 AM
$JNJ extend higher as anticipated in (5) that ended at 281 high within rally from daily #bluebox area Now it should either correcting rally from May-2026 low before continue rally or can be correcting big against Jan-2025 low. Chasing long at this stage is risky. #Elliottwave
0 · Reply
HydrogenH2
HydrogenH2 Jul. 31 at 11:06 AM
$DJT $UNH $JNJ $SPY https://www.theguardian.com/commentisfree/2026/jul/30/us-public-rfk-jr-america-healthy-europe-wellness-fads
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Jul. 31 at 4:22 AM
Top Stock Losers Today — July 30, 2026: $JNJ -- −2.54% $DIS -- −2.53% $JMKE -- −9% From IPO Price $MAGNUM.NSE https://truthsandnews.com/markets/10-top-stock-losers-today-july-30-2026-carvana-arm
0 · Reply
Game_Day
Game_Day Jul. 31 at 1:02 AM
On watch JULY 31s ☀️ 🏝️ $AAPL trending 315 to 317 to 320+ $JNJ 256.80+ $FSLR excellent earnings am breakout $SKYQ potential low float And bonus 🎁 watch DHR Follow for great watch tickers
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 31 at 12:53 AM
$JNJ should continue rally targeting 271.37 or higher within daily bull run against May-2026 low. Short term pullback against 6.22.2026 low should remain supported to continue rally to extend ((5)). Check out the details at https://elliottwave-forecast.com/stock-market/jnj-elliott-wave-bullish-rally-targets-271-37-beyond/ #Elliottwave #JNJ
0 · Reply
profit_guru
profit_guru Jul. 31 at 12:33 AM
$ABBV - most popular drug skyrizi will have new competition from $JNJ FDA approved icotyde
1 · Reply
clan
clan Jul. 30 at 10:33 PM
$JNJ $ABBV $GSK If you know Dry Powder Inhalation (DPI), you know it's great for all Mannkind. 🚫💉
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 30 at 7:52 PM
0 · Reply
Pearl_Power
Pearl_Power Jul. 30 at 4:45 PM
$JNJ sector rotation $XLV $SOXX
0 · Reply
GreenEnergy7B
GreenEnergy7B Jul. 30 at 3:49 PM
$ALT Best AUD data seen to date. GLP1 + Glucagon gives patients so many benefits $PFE $NVS $JNJ $BMY
0 · Reply
HydrogenH2
HydrogenH2 Jul. 30 at 3:38 PM
$JNJ Next stop @$250 !!
0 · Reply
profit_guru
profit_guru Jul. 30 at 2:36 PM
$JNJ - another golden chance to load up best pharma company with strong growth cheap…might close above 260
0 · Reply
FlowAnomaly
FlowAnomaly Jul. 30 at 2:33 PM
$JNJ interesting call coming in
0 · Reply
BarkingPuppy
BarkingPuppy Jul. 30 at 2:28 PM
$PFE $JNJ Which one of you guys are buying ELTP?
0 · Reply
HydrogenH2
HydrogenH2 Jul. 30 at 2:12 PM
$JNJ "Double Top" ??
0 · Reply